Small sips of an electrolyte drink or even clear broth can provide hydration without causing the bloating that sometimes comes from drinking large amounts of water at once
These are conversations to have with a physician before making the change, not decisions to make in a Mexican pharmacy aisle

Key Points Native human GLP-1 normalizes hyperglycaemia in patients with type 2 diabetes mellitus, but the short in vivo half-life of this hormone limits its therapeutic application A number of synthetic GLP-1 receptor agonists, with half-lives between 23 h and several days, have been developed for the long-term treatment of type 2 diabetes mellitus Short-acting GLP-1 receptor agonists (such as exenatide and lixisenatide) predominantly lower postprandial glucose levels and insulin concentrations via retardation of gastric emptying Long-acting GLP-1 receptor agonists (such as albiglutide, dulaglutide, exenatide long-acting release and liraglutide) predominantly lower blood glucose levels through stimulation of insulin secretion and reduction of glucagon levels Adverse effects of GLP-1 receptor agonists include nausea, vomiting and diarrhoea, injection-site reactions, antibody formation and increased heart rate This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

Additionally, if you are diabetic and currently taking diabetic medication or taking insulin, you have a history of pancreatitis, gallbladder issues or you have a personal or family history of medullary thyroid carcinoma (thyroid cancer), you should avoid using GLP-1 injections
This can help you stay sharp and alert, making it an attractive option for individuals seeking optimal mental performance